跳转至内容
Merck
CN

830865P

Avanti

18:0 PA

Avanti Research - A Croda Brand

别名:

1,2-二十八烷酰基-sn-甘油-3-磷酸酯(钠盐);DSPA;PA(18:0/18:0)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C39H76O8PNa
化学文摘社编号:
分子量:
726.98
MDL number:
UNSPSC Code:
51191904
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

1,2-distearoyl-sn-glycero-3-phosphate (sodium salt)

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 25 mg (830865P-25mg), pkg of 1 × 500 mg (830865P-500mg)

manufacturer/tradename

Avanti Research - A Croda Brand

lipid type

cardiolipins
phospholipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

[Na+].[P](=O)([O-])(OC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC)O

InChI

1S/C39H77O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h37H,3-36H2,1-2H3,(H2,42,43,44);/q;+1/p-1/t37-;/m1./s1

InChI key

ALPWRKFXEOAUDR-GKEJWYBXSA-M

General description

磷脂酸(PA)具有两个脂肪酸和一个磷酸盐,连接到甘油主链的磷酸盐。这两种脂肪酸存在于C原子的sn-1和sn-2位置,磷酸盐基存在于C原子的sn-3位置。

Application

18:0 PA可用于:
  • 作为双层膜的成分,研究其对不同外壳蛋白I(COPI)裂变因子的囊泡形成能力,
  • 研究其对C6大鼠胶质瘤和L2071小鼠成纤维细胞内Ca2+浓度([Ca2+]i)的影响
  • 研究其对细胞色素b(558)α链(p22phox)磷酸化的影响

Biochem/physiol Actions

磷脂酸(PA)充当生产膜甘油磷脂和三酰基甘油的生物合成前体。它参与调节哺乳动物雷帕霉素靶蛋白(mTOR)途径。它也可能参与膜运输,特别是膜融合和裂变。

Packaging

20 mL透明玻璃螺旋盖小瓶(830865P-500mg)
5 mL棕色玻璃螺旋盖小瓶(830865P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Yang Liu et al.
Nature communications, 10(1), 5108-5108 (2019-11-11)
Mounting evidence suggests that the tumor microenvironment is profoundly immunosuppressive. Thus, mitigating tumor immunosuppression is crucial for inducing sustained antitumor immunity. Whereas previous studies involved intratumoral injection, we report here an inhalable nanoparticle-immunotherapy system targeting pulmonary antigen presenting cells (APCs)
Seung-Yeol Park et al.
Nature communications, 10(1), 3409-3409 (2019-08-01)
Studies on vesicle formation by the Coat Protein I (COPI) complex have contributed to a basic understanding of how vesicular transport is initiated. Phosphatidic acid (PA) and diacylglycerol (DAG) have been found previously to be required for the fission stage
Qiang Cheng et al.
Nature nanotechnology, 15(4), 313-320 (2020-04-07)
CRISPR-Cas gene editing and messenger RNA-based protein replacement therapy hold tremendous potential to effectively treat disease-causing mutations with diverse cellular origin. However, it is currently impossible to rationally design nanoparticles that selectively target specific tissues. Here, we report a strategy



全球贸易项目编号

货号GTIN
830865P-25MG04061835228461
830865P-500MG04061835228478